What over-the-counter (OTC) medications are recommended for treating sinus congestion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

OTC Medications for Sinus Congestion

For sinus congestion, pseudoephedrine (Sudafed) is the most effective oral decongestant available over-the-counter, while intranasal corticosteroids like fluticasone (Flonase) provide superior overall symptom control for congestion lasting more than a few days. 1, 2

First-Line Options Based on Duration and Severity

For Acute, Short-Term Relief (≤3 days)

  • Topical nasal decongestants (oxymetazoline/Afrin) provide the most rapid relief, working within minutes with minimal systemic effects 1, 3
  • These are appropriate for acute viral infections, sinusitis exacerbations, and Eustachian tube dysfunction 1, 3
  • Critical warning: Never use topical decongestants beyond 3 days due to risk of rhinitis medicamentosa (rebound congestion), though some patients develop this as early as 3 days while others tolerate 4-6 weeks 1

For Ongoing Congestion (>3 days)

  • Intranasal corticosteroids (fluticasone, mometasone) are the most effective medication class for controlling nasal congestion and should be considered before oral decongestants 1, 4
  • These work by reducing inflammatory cell infiltration and vascular permeability, providing superior symptom control compared to oral decongestants alone 1
  • Patients must direct sprays away from the nasal septum to minimize risk of irritation and bleeding 1

Oral Decongestants

  • Pseudoephedrine (30-60 mg every 4-6 hours) is significantly more effective than phenylephrine due to better oral bioavailability 1, 2, 5
  • Phenylephrine is extensively metabolized in the gut and its efficacy as an oral decongestant has not been well established 1, 2
  • Pseudoephedrine provides objective improvement in nasal airway resistance and subjective congestion scores in both single and multiple-dose studies 6

Safety Considerations and Contraindications

Cardiovascular Concerns

  • Pseudoephedrine causes small increases in systolic blood pressure (0.99 mmHg) and heart rate (2.83 beats/min) through α-adrenergic vasoconstriction 3, 2
  • Blood pressure elevation is very rarely noted in normotensive patients and only occasionally in those with controlled hypertension 1
  • Use with extreme caution in patients with hypertension, arrhythmias, coronary artery disease, cerebrovascular disease, hyperthyroidism, or closed-angle glaucoma 1, 2
  • For patients with controlled hypertension requiring decongestant therapy, topical oxymetazoline for ≤3 days is safer than oral pseudoephedrine 3
  • Never combine oral and topical decongestants due to risk of hypertensive crisis from combined vasoconstrictive effects 3

Pediatric Use

  • Oral decongestants are well tolerated in children over 6 years when used at appropriate doses 1
  • Avoid in children under 6 years due to reports of agitated psychosis, ataxia, hallucinations, and even death 1, 2

Drug Interactions

  • Concomitant use with caffeine, stimulants (ADHD medications), or other sympathomimetics increases risk of adverse events 1, 3

Combination Therapy Considerations

  • The efficacy of combining oral decongestants with antihistamines has not been adequately documented to increase efficacy beyond either drug alone 1
  • For allergic rhinitis with congestion, intranasal corticosteroids are more efficacious than combining an antihistamine with an oral decongestant 1
  • Antihistamines alone have little objective effect on nasal congestion, though second-generation agents like desloratadine may provide modest benefit 1, 7

Practical Algorithm

  1. Day 1-3 of acute congestion: Topical oxymetazoline (Afrin) for rapid relief 3
  2. Beyond day 3: Switch to intranasal corticosteroid (fluticasone) as primary therapy 1, 4
  3. If additional relief needed: Add pseudoephedrine (not phenylephrine) for short-term use 1, 2
  4. For patients with cardiovascular disease: Prioritize intranasal corticosteroids; avoid oral decongestants if possible 3
  5. Monitor blood pressure in hypertensive patients receiving any decongestant therapy 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Oral Decongestants for Nasal Congestion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Decongestant Safety and Efficacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.